MedTrace Logo

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

NCT05837819 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2026-05-11

No results posted yet for this study

Summary

Aim 2 will investigate the effect of 3 different light exposure lengths on sleep, mood and agitation in persons with Alzheimer's disease. Participants will be randomly assigned to one of three conditions of light exposure: 1) 2-h morning light exposure; 2) 4-h morning light exposure; and 3) all day light exposure.

Conditions

Interventions

DEVICE

Active Lighting Intervention

Lighting intervention using high light levels designed to effect the circadian system

DEVICE

Control Lighting Intervention

Lighting intervention using low light levels designed to not effect the circadian system

Sponsors & Collaborators

Principal Investigators

  • Mariana Figueiro, PhD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-14
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05837819 on ClinicalTrials.gov